Anzeige
Mehr »
Samstag, 14.02.2026 - Börsentäglich über 12.000 News
20 Mio. € Bewertung. Zwei zugelassene Psychedelika-Produkte. NASDAQ-Uplist in Arbeit.
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
19 Leser
Artikel bewerten:
(0)

Philips honors innovation in radiation dose management with the 3rd Annual ISRRT Dosewise Radiographer of the Year contest

ISRRT and Philips highlight global efforts to optimize radiation dose exposure

ANDOVER, Massachusetts, July 28, 2015 /PRNewswire/ -- Royal Philips (NYSE: PHG, AEX: PHIA) today launched the 3rd Annual "ISRRT Dosewise Radiographer of the Year" contest to further increase awareness about the risks of radiation dose exposure during diagnostic image testing. The annual contest, conducted in partnership with the International Society of Radiographers and Radiological Technologists (ISRRT), recognizes dose-conscious radiographers from around the world for their contribution in improving dose tracking and measurement and efforts toward overall radiation dose reduction.

Logo - http://photos.prnewswire.com/prnh/20140122/NE50581LOGO

As one of the early pioneers of radiation dose management solutions, Philips extended its leadership with the launch of the DoseWise Portal, a comprehensive radiation dose management software solution that monitors dose exposure risk for patients and clinicians. It allows providers to proactively record, analyze and monitor imaging radiation dose for patients and clinicians across multiple diagnostic settings. The solution automates monitoring and tracking, facilitating compliance with reform and accreditation requirements. The "ISRRT Dosewise Radiographer of the Year" contest is geared to encourage innovation and generate new ways to manage radiation dose risk.

"With patients and clinicians becoming more aware of the risks of radiation dose exposure, developing lower dose solutions is becoming a top priority for hospital and health systems," said Dominic Siewko, Director of Clinical Dose Management at Philips. "Over the past few years, we've seen some of the most innovative research to address this challenge, and this contest is designed to further encourage new ideas and reinforce our commitment to collaborating with clinicians and scientists around effective radiation dose management programs."

Judged by ISRRT members, the Radiographer of the Year will be selected based on the project that best demonstrates dose management practices. Applications are open for practicing radiographers who are citizen of an ISRRT Member Country or an Associate Member of ISRRT. Entrants must complete an online quiz and also provide a written submission. ISRRT will provide the Radiographer of the Year with airfare and entry to Radiological Society of North America's (RSNA) Annual Meeting for 2015, and the opportunity to present their entry to their peers.

Last year's content winner, Dr. Sonyia McFadden, Lecturer, Diagnostic Radiography at the University of Ulster, Belfast, UK received the award for her research, entitled, "Dose Optimization in Pediatric Interventional Cardiology." Dr. McFadden surveyed hospitals in Ireland and found a variation in practice and protocols for pediatric imaging, which was directly impacting radiation dose exposure for children.

The deadline for submission is September, 30 2015. For rules and to access the application, visit www.philips.com/dosewise-contest.

Philips is also launching the first Iterative Model Reconstruction (IMR) "Case of the Year" contest, designed to identify industry leaders using lower dose and higher resolution technologies to improve diagnostic confidence. Contest winners will be recognized at RSNA. For more information, visit the IMR contest page.

To learn more about Philips' innovations in radiation dose management, visit www.philips.com/dosewise and follow the conversation @PhilipsHealth.

For further information, please contact:
Kathy O'Reilly
Philips Group Communications
(mobile) 978-221-8919
Kathy.oreilly@philips.com
Twitter: @kathyoreilly

About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people's lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2014 sales of EUR 21.4 billion and employs approximately 108,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

© 2015 PR Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.